Search
Search Results
##search.searchResults.foundPlural##
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3779PDF: 1597HTML: 8053Randi Fig: 189 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3721PDF: 1309HTML: 746Figure 2: 459Figure 1: 3128 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3259PDF: 913HTML: 1544Fig.1 CHL-R paper: 227Fig 2 CHL-R paper: 249 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1739PDF: 1109HTML: 10706Untitled: 196 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2399PDF: 847HTML: 2159New table Chinese children with APL: 164 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2229PDF: 2063HTML: 199 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1517PDF: 1088HTML: 223 -
-
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1745PDF: 1455HTML: 254 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1314PDF: 947HTML: 91 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3099PDF: 886HTML: 7172Kost Fig1: 195Kost Fig 2: 187Kost Fig3: 186Kost Fig 4: 199Kost Fig5: 194Kost fig 6: 181 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1791PDF: 1004HTML: 1792Tables: 182 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2049PDF: 814HTML: 1112 -
-
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1133PDF: 780HTML: 321 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
832PDF: 545HTML: 4026 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4338PDF: 1198HTML: 2183Figure 1: 170 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
1998PDF: 79HTML: 22 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
718PDF: 551HTML: 220 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3230PDF: 789HTML: 2973Figure 1a and 1b: 154Figure 2: 164Figure 3: 182Figure 4: 167Figure 5: 168Tables 1-5: 156 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2887PDF: 859HTML: 6533Untitled: 238Untitled: 201Untitled: 213Untitled: 225 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1214PDF: 607HTML: 6804 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7672PDF: 2448HTML: 1742Table 1.: 217Table 2.: 227Table 3.: 211Table 4.: 210 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2499PDF: 797HTML: 1738 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2126HTML: 555PDF: 1314 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2309PDF: 622Suppl. Files: 286HTML: 178 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3724PDF: 1629HTML: 80







